Method of Obtaining Casein from Skim Milk using Oligochitosans |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.8, No. 4)Publication Date: 2020-04-08
Authors : LR Alieva; IA Evdokimov; AD Lodygin; BE Tikhonov; NV Sushinskaia; VP Kurchenko;
Page : 331-334
Keywords : Oligochitosan; a-casein; b-casein; K-casein; b-lactoglobulin;
Abstract
The interaction of milk proteins and oligochitosansis based on formation of electrostatic complex between negatively charged casein micelles and positively charged polysaccharide groups. At low concentrations of oligochitosans, partial interaction with milk proteins occurs. Maximum protein coagulation (90 %) is achieved in equivalence zone at the concentration of oligochitosans: 45.3 kDa-0.88×10-4 M; 25.4 kDa-1.57×10-4 M; 7.7 kDa – 5.19×10-4 M; 1.5 kDa-26.67×10-4 M. In these concentrations, taking into account the molecular weight and degree of deacetylation of oligochitosans, the total content of protonated amino groups is equal 2.4×10-4 M. When t protein content in skimmed milk is 3.0 % - 3.2%, oligochitosans of any molecular weight and degree of deacetylation can be used for casein coagulation, important that the final concentration of amino groups should be 2.4×10-4 M. It was determined that the use of the studied samples of oligochitosan allows to obtain coacervate where 1g of oligochitosan binds 6.0 - 6.2g of milk proteins.
Other Latest Articles
- A Note on Prebiotics Strategy to Cope with Current Health Challenges in Human Beings |Biomedgrid
- Nigeria is the Next Destination of COVID-19 (Coronavirus) Patients Across the Globe, But the Strategic Plan for Medical Laboratories is in the Pipeline |Biomedgrid
- Nanoparticles in Dentistry: Evidence and Future |Biomedgrid
- Alliesthesia. Up-date of the Word and Concept |Biomedgrid
- Historical and Current Conditions Including COVID-19 Requiring Anti-Pathogenic Surveillance and Proper Immunogenic Support |Biomedgrid
Last modified: 2023-06-08 21:56:30